The effect of Bromelain and Montelukast in Covid-19 patients

Phase 3

Recruiting

• Conditions: SARS-COV-2.; Coronavirus infection, unspecified; B34.2

• Registration Number: IRCT20150725023332N3
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Infection with coronavirus is new

Exclusion Criteria

History of severe liver disease
History of severe respiratory disorders
BMI <12

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in lymphocyte levels. Timepoint: Before intervention , 1 hour later, 6 hours later and 12 hours after the intervention. Method of measurement: Biochemical and immunological tests.;CRP. Timepoint: Before intervention , 1 hour later, 6 hours later and 12 hours after the intervention. Method of measurement: Biochemical test.